安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Apixaban Uses, Side Effects Warnings - Drugs. com
What is apixaban? Apixaban is used to lower the risk of stroke and blood clots in adults with a heart rhythm disorder called atrial fibrillation not caused by a heart valve problem
- Apixaban (oral route) - Side effects dosage
Apixaban is a factor Xa inhibitor, an anticoagulant It works by decreasing the clotting ability of the blood and helps preventing harmful clots from forming in the blood vessels This medicine is available only with your doctor's prescription
- Apixaban - Wikipedia
Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with atrial fibrillation and a CHA2DS2-VASc score ≥ 2
- Eliquis (Apixaban): Uses Side Effects - Cleveland Clinic
Eliquis (apixaban) is a blood thinner your doctor prescribes to treat and prevent blood clots and lower stroke risk if you have atrial fibrillation
- Eliquis (apixaban): Uses, Side Effects, Interactions, Pictures . . . - WebMD
Find patient medical information for Eliquis (apixaban) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Rx ELIQUIS® (apixaban) Home Page | Safety Info
ELIQUIS (apixaban) is a prescription medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem
- Eliquis (apixaban) dosing, indications, interactions, adverse effects . . .
Medscape - Thromboembolism prevention dosing for Eliquis (apixaban), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost
- Apixaban: AFib Uses, Side Effects, Dosage - MedicineNet
Apixaban is a prescription blood thinning medication used to prevent blood clots in the heart and strokes in patients with atrial fibrillation (AFib, AF), and to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism
|
|
|